Search results for "interleukin"

showing 10 items of 1856 documents

T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity.

2005

SummaryHuman parvovirus B19 is a small non-enveloped DNA virus with an icosahedral capsid consisting of proteins of only two species, the major protein VP2 and the minor protein VP1. VP2 is contained within VP1, which has an additional unique portion (VP1u) of 227 amino acids. We determined the ability of eukaryotically expressed parvovirus B19 virus-like particles consisting of VP1 and VP2 in the ratio recommended for vaccine use, or of VP2 alone, to stimulate, in an HLA class II restricted manner, peripheral blood mononuclear cells (PBMC) to proliferate and to secrete interferon gamma (IFN-γ) and interleukin (IL)-10 cytokines among recently and remotely B19 infected subjects. PBMC reactiv…

AdultMalevirusesImmunologyPeripheral blood mononuclear cellVirusParvoviridae Infections03 medical and health sciencesEpitopesInterferon-gammaAntigenPregnancymedicineParvovirus B19 HumanImmunology and AllergyHumansInterferon gammaPregnancy Complications InfectiousCells Cultured030304 developmental biologyParvoviridae0303 health sciencesImmunity Cellularbiology030306 microbiologyParvovirusHistocompatibility Antigens Class IIInterleukinvirus diseasesT helper cellT-Lymphocytes Helper-InducerOriginal ArticlesMiddle Agedbiology.organism_classificationVirology3. Good healthInterleukin-10Endotoxinsmedicine.anatomical_structureImmunologyLeukocytes MononuclearCapsid ProteinsFemaleCell Divisionmedicine.drugClinical and experimental immunology
researchProduct

Antibody microarray analysis of the serum proteome in primary breast cancer patients

2011

Noninvasive biomarkers are urgently needed for detecting breast cancer as early as possible since the risk of recurrence, morbidity, and mortality is closely related to disease stage at the time of primary surgery. There are currently no such biomarkers in clinical use as a diagnostic tool. Proteomic analysis of protein expression patterns in body fluids has potential for use in identifying biomarkers of breast cancer. The aim of this study was to compare protein expression levels in the sera of primary breast cancer patients and healthy controls. An antibody microarray tool with 23 antibodies immobilized on nitrocellulose slides was used to determine the levels of acute phase proteins, int…

AdultOncologyCancer Researchmedicine.medical_specialtyProteomeAntibody microarrayProtein Array AnalysisBreast NeoplasmsDiseaseBreast cancerInternal medicineBiomarkers TumorHumansMedicineStage (cooking)AgedAged 80 and overImmunoassayPharmacologybiologybusiness.industryAcute-phase proteinInterleukinMiddle Agedmedicine.diseaseOncologyCase-Control StudiesImmunologybiology.proteinMolecular MedicineFemaleNeoplasm GradingAntibodybusinessPrimary breast cancerCancer Biology & Therapy
researchProduct

The Maternal Cytokine and Chemokine Profile of Naturally Conceived Gestations Is Mainly Preserved duringIn VitroFertilization and Egg Donation Pregna…

2015

This prospective longitudinal study aimed at comparing maternal immune response among naturally conceived (NC;n=25),in vitrofertilization (IVF;n=25), and egg donation (ED;n=25) pregnancies. The main outcome measures were, firstly, to follow up plasma levels of interleukin (IL) 1beta, IL2, IL4, IL5, IL6, IL8, IL10, IL17, interferon gamma, tumor necrosis factor-alpha (TNFα), transforming growth factor-beta (TGFβ), regulated upon activation normal T-cell expressed and secreted (RANTES), stromal cell-derived factor 1 alpha (SDF1α), and decidual granulocyte-macrophage colony-stimulating factor (GM-CSF) during the three trimesters of pregnancy during the three trimesters of pregnancy; secondly, t…

AdultProteomicslcsh:Immunologic diseases. Allergymedicine.medical_specialtyChemokineArticle SubjectT-Lymphocytesmedicine.medical_treatmentImmunologyFertilization in VitroPreeclampsiaPregnancyInternal medicinemedicineCluster AnalysisHumansImmunology and AllergyLongitudinal StudiesProspective StudiesInterleukin 8Pregnancy TrimestersPregnancyIn vitro fertilisationbiologybusiness.industryImmunityPregnancy OutcomeGeneral Medicinemedicine.diseaseInterleukin 10Endocrinologybiology.proteinCytokinesGestationFemalePregnancy TrimestersChemokineslcsh:RC581-607businessBiomarkersResearch ArticleJournal of Immunology Research
researchProduct

Long-term outcome of treatment with dacarbazine, cisplatin, interferon-α and intravenous high dose interleukin-2 in poor risk melanoma patients

1998

Melanoma patients with very advanced disease are usually excluded from chemoimmunotherapy trials; however, the efficacy of intensive treatment regimens needs to be established for this patient population. This study aimed to evaluate the response rate and survival achieved with chemoimmunotherapy in very advanced melanoma patients. Forty-two patients received dacarbazine (250 mg/m2, days 1-3), cisplatin (30mg/m2, days 1-3), interferon-alpha (10 Mio IU/m2 subcutaneously, days 1-5) and intravenous interleukin-2 (18 Mio IU/m2 over 6 h, 12 h then 24 h, followed by 13.5 MioIU/m2 in 72 h). In cases of brain metastases (n = 12) radiation therapy was added. Ten patients (24%) achieved a partial res…

AdultRiskInterleukin 2Cancer Researchmedicine.medical_specialtySkin NeoplasmsTime Factorsmedicine.medical_treatmentDacarbazineDermatologyGastroenterologyStable DiseaseChemoimmunotherapyInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansNeoplasm MetastasisMelanomaAgedResponse rate (survey)CisplatinL-Lactate DehydrogenaseBrain Neoplasmsbusiness.industryMelanomaInterferon-alphaMiddle AgedPrognosismedicine.diseaseDacarbazineSurvival RateRadiation therapyTreatment OutcomeOncologyInterleukin-2Cisplatinbusinessmedicine.drugMelanoma Research
researchProduct

Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human long…

2005

In this paper, we review data of recent literature on the distribution in centenarians of candidate germ-line polymorphisms that likely affect the individual chance to reach the extreme limit of human life. On the basis of previous observations on the immunology, endocrinology and cellular biology of centenarians we focused on genes that regulate immune responses and inflammation (IL-6, IL-1 cluster, IL-10), genes involved in the insulin/IGF-I signalling pathway and genes that counteract oxidative stress (PON1). On the whole, data indicate that polymorphisms of these genes likely contribute to human longevity, in accord with observations emerging from a variety of animal models, and suggest…

AdultSenescenceAgingCandidate geneGenotypemedia_common.quotation_subjectLongevityBiologyModels BiologicalGenomeImmune systemHumansInsulinInsulin-Like Growth Factor IGeneAgedmedia_commonAged 80 and overInflammationGeneticsPolymorphism GeneticAryldialkylphosphataseInterleukin-6Age FactorsImmunityLongevityHedgehog signaling pathwayInterleukin-10Oxidative StressMultigene FamilyFunction (biology)Interleukin-1Signal TransductionDevelopmental BiologyMechanisms of Ageing and Development
researchProduct

IL-10 and TNF-α polymorphisms in a sample of sicilian patients affected by tuberculosis: implication for ageing and life span expectancy

2003

Abstract Human longevity seems to be directly correlated with optimal functioning of the immune system, suggesting that some genetic determinants of longevity might reside in those polymorphisms for the immune system genes that regulate immune responses, in particular cytokine gene polymorphisms. In fact, modification of cytokine network is a constant report in studies on age related modification of immune response. Moreover cytokine polymorphisms studies are indicating their involvement in the reshaping of cytokines network as an integral part of the scenario related to a successful ageing. A particular role might be attributed to the influence of cytokine polymorphisms on the efficiency o…

AdultSenescenceAgingGenotypemedicine.medical_treatmentmedia_common.quotation_subjectSingle-nucleotide polymorphismDiseaseBiologyPolymorphism Single NucleotideLife ExpectancyImmune systemGene FrequencymedicineHumansSicilyTuberculosis Pulmonarymedia_commonTumor Necrosis Factor-alphaLongevityMiddle AgedInterleukin-10Interleukin 10CytokineAgeingImmunologyDevelopmental BiologyMechanisms of Ageing and Development
researchProduct

A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis

2003

Abstract Objective . The interleukin-1 (IL-1) family, that is, IL-1α and β and the IL-1 receptor antagonist (IL-1RA), is known to modulate various tumorgenic and tumorcidal effects in humans. Its biological function in squamous cell carcinogenesis of various anatomical sites has been stressed. Although various studies showed a certain association between genes encoding the IL-1 family and human malignancies, no data with respect to vulvar cancer have been published to date. Methods . We ascertained four polymorphisms of the IL-1α gene ( IL1A C[−889]T), the IL-1β gene ( IL1B promoter C[-511]T and IL1B exon 5 position +3953), and the IL-1RA gene ( IL1RN intron 2) in 68 patients with surgicall…

AdultSialoglycoproteinsBiologyBioinformaticsmedicine.disease_causePolymerase Chain ReactionExonGene clustermedicineHumansPromoter Regions GeneticAllelesAgedNeoplasm StagingAged 80 and overVulvar neoplasmPolymorphism GeneticVulvar NeoplasmsObstetrics and GynecologyInterleukinExonsMiddle AgedVulvar cancermedicine.diseaseInterleukin 1 Receptor Antagonist ProteinCell Transformation NeoplasticInterleukin 1 receptor antagonistOncologyIL1AMultigene FamilyCarcinoma Squamous CellCancer researchFemaleCarcinogenesisInterleukin-1Gynecologic Oncology
researchProduct

Regulation of immunomodulatory functions by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in vivo

1996

The present study was designed to investigate in vivo immunomodulatory properties of hematopoietic growth factors. The influence on the activation of cytokine synthesis and on the expression of surface antigens associated with cellular activation of G-CSF or GM-CSF was investigated in cancer patients receiving these factors. One single dose of growth factor was administered to patients with bladder cancer (G-CSF group) or small cell lung cancer (GM-CSF group) before chemotherapy. After cytoreductive chemotherapy patients received supportive therapy with G-CSF or GM-CSF. Peripheral blood mononuclear cells and plasma samples were obtained for flow cytometry, Northern blot analysis, and assess…

AdultSialoglycoproteinsmedicine.medical_treatmentBiologyPeripheral blood mononuclear cellAdjuvants ImmunologicGranulocyte Colony-Stimulating FactormedicineHumansRNA MessengerGrowth SubstancesInterleukin 6AgedInterleukin-6MonocyteGrowth factorInterleukin-8Granulocyte-Macrophage Colony-Stimulating FactorReceptors Interleukin-1Receptors Interleukin-2HematologyGeneral MedicineMiddle AgedHematopoietic Stem CellsRecombinant ProteinsGranulocyte colony-stimulating factorInterleukin 1 Receptor Antagonist ProteinHaematopoiesisGranulocyte macrophage colony-stimulating factormedicine.anatomical_structureCytokineSolubilityAntigens SurfaceImmunologyCancer researchbiology.proteinmedicine.drugAnnals of Hematology
researchProduct

Long-Term Human CD34+ Stem Cell-Engrafted Nonobese Diabetic/SCID/IL-2Rγnull Mice Show Impaired CD8+ T Cell Maintenance and a Functional Arrest of Imm…

2010

Abstract Allogeneic hematopoietic stem cell transplantation represents the most effective form of immunotherapy for chemorefractory diseases. However, animal models have been missing that allow evaluation of donor-patient–specific graft-versus-leukemia effects. Thus, we sought to establish a patient-tailored humanized mouse model that would result in long-term engraftment of various lymphocytic lineages and would serve as a donor-specific surrogate. Following transfer of donor-derived peripheral blood stem cells into NOD/SCID/IL-2Rγnull (NSG) mice with supplementation of human IL-7, we could demonstrate robust engraftment and multilineage differentiation comparable to earlier studies using …

AdultT cellTransplantation HeterologousImmunologyAntigens CD34Graft vs Leukemia EffectMice TransgenicMice SCIDCD8-Positive T-LymphocytesBiologyMiceInterleukin 21Immune systemMice Inbred NODmedicineAnimalsHumansImmunology and AllergyCytotoxic T cellCell LineageMice KnockoutMice Inbred BALB CCell DeathHematopoietic Stem Cell TransplantationCell DifferentiationKiller Cells NaturalMice Inbred C57BLmedicine.anatomical_structureCord bloodImmunologyHumanized mouseLymphocyte Culture Test MixedStem cellK562 CellsCD8Interleukin Receptor Common gamma SubunitThe Journal of Immunology
researchProduct

Modifications in the production of cytokines and growth factors in drainage fluids following mesh implantation after incisional hernia repair

2005

Abstract Background The aim of this study was to evaluate changes in the production of some cytokines (interleukins [ILs]-6, -10, -1, and -1ra), vascular endothelial growth factor, and beta-fibroblast growth factor after polypropylene mesh implantation. Methods Twenty female patients were divided into 2 groups. In 1 group, hernia repair was performed with conventional sutures (CR), whereas in the other group polypropylene mesh (MR) was used. Growth factors and cytokines production was analyzed in wound drain fluids based on the amount produced during 24 hours. Results IL-1 increased substantially in MR patients on postoperative days 1 and 2. IL1-ra and IL-10 production was always significan…

AdultVascular Endothelial Growth Factor Amedicine.medical_specialtyincisional herniaIncisional herniamedicine.medical_treatmentEnzyme-Linked Immunosorbent AssayPolypropyleneschemistry.chemical_compoundmedicineHumansHerniaProspective StudiesPostoperative CareLaparotomyPain Postoperativebusiness.industryInterleukinsGrowth factorSuture Techniquesgrowth factorGeneral MedicineMiddle AgedSurgical Meshmedicine.diseaseHernia repairHernia Ventralinterieukinmesh implantationSurgeryVascular endothelial growth factorTreatment OutcomeCytokineSurgical meshchemistryCytokinesFemaleSurgeryInflammation MediatorsVascular endothelial growth factor productionbusinessFollow-Up Studies
researchProduct